Despite advances in antifungal prophylaxis and therapy, morbidity and mortality incurred by
yeasts remain a significant burden. As pathogenic yeast species vary in their susceptibilities
to antifungal agents, clinical microbiology laboratories face an important challenge to
identify them rapidly and accurately. Although a vast array of phenotyping and genotyping
methods has been developed, these are either unable to cover the whole spectrum of
potential yeast pathogens or can do this only in a rather costly or laborious way. Random …